Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001069356 | SCV001234518 | uncertain significance | Developmental and epileptic encephalopathy, 36 | 2022-08-27 | criteria provided, single submitter | clinical testing | This variant, c.2879_2881dup, results in the insertion of 1 amino acid(s) of the ALG13 protein (p.Pro960dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ALG13-related conditions. ClinVar contains an entry for this variant (Variation ID: 862605). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Fulgent Genetics, |
RCV001069356 | SCV002797666 | uncertain significance | Developmental and epileptic encephalopathy, 36 | 2022-05-10 | criteria provided, single submitter | clinical testing | |
| Neuberg Centre For Genomic Medicine, |
RCV001069356 | SCV002820217 | uncertain significance | Developmental and epileptic encephalopathy, 36 | criteria provided, single submitter | clinical testing | The inframe insertion variant c.2879_2881dup (p.Pro960dup) in ALG13 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Pro960dup variant is reported with the allele frequency (0.007%) in the gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The inframe insertion This p.Pro960dup causes duplication of amino acid Proline at postion 960. For these reasons, this variant has been classified as Variant of Uncertain Significance (VUS). | |
| Ambry Genetics | RCV002555884 | SCV003739625 | likely benign | Inborn genetic diseases | 2022-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |